Shares of Vertex Pharmaceuticals rose 8% in off-hours trading after the pharmaceutical company won U.S. approval for the [first new non-opioid painkiller in decades]( ...
The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for ...
The Food and Drug Administration on Tuesday approved Journavx, the first drug in a new class of non-opioid pain medications, ...